Wednesday, September 23, 2015 3:52:16 PM
We really have a lot going on with the pipeline here. Price should and will most likely be much higher in near future.
In Reply to 'To infinity and beyond!'
Not to mention the following future pr's:
Next to last patient has completed enrollment in Kevetrin Phase 1 trial
Final patient completes enrollment in Kevetrin Phase 1 trial
CTIX announces a guess when the Bologna AML trial will begin: we announced it was starting soon about a year ago, so who knows really. We don't know- the country is just getting back from vacation and returning to work. So submit your guess and one day, sometime in the next year or two , maybe, we shall see. Guesses may be sumitted directly at Beverly office- we promise someone will be there to answer the door- it's not empty as some nefarious individuals suggest
Cellceutix announces possible upcoming discussions with FDA about Hidradenitis Suppurativa. Just wait until we know more about Brilacidin OM, even though earlier we were going to meet with them anyway. It is now on a back burner. But at least it's on a burner.
CTIX announces potential jackpot indication for ulcerative proctitis, but only once more is known about Brilacidin OM, which will take a long time. But maybe at some future point it will be a big winner for us and proctitis sufferers. Also on the back burner.
CTIX says the new gram negative drug 1807 might fit on the stove but burners are crowded.
CTIX says it will re-release previous old favorite PR's. Look we just re-released the Brilacidin hip joint materials announcement. Let us know what other your other favorites are and we will consider them for regifting. The disappearing spleen lesion? They're all on the table, get in line.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM